BRIACELL THERAPEUTICSCS CORP - WARRANT
Share · CA10778Y1126 · BCTXW (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BRIACELL THERAPEUTICSCS CORP - WARRANT
No Price
Company Profile for BRIACELL THERAPEUTICSCS CORP - WARRANT Share
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Company Data
Name BRIACELL THERAPEUTICSCS CORP - WARRANT
Company BriaCell Therapeutics Corp.
Symbol BCTXW
Website
https://briacell.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN CA10778Y1126
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO William V. Williams FCPA,
Country Canada
Currency USD
Employees 0,0 T
Address Bellevue Centre, V7T 2X1 West Vancouver
IPO Date 2012-08-13
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | BCTXW |
More Shares
Investors who hold BRIACELL THERAPEUTICSCS CORP - WARRANT also have the following shares in their portfolio:
